"Azathioprine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
| Descriptor ID |
D001379
|
| MeSH Number(s) |
D02.886.759.111 D03.633.100.759.534.090 D13.570.900.111
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Azathioprine".
Below are MeSH descriptors whose meaning is more specific than "Azathioprine".
This graph shows the total number of publications written about "Azathioprine" by people in this website by year, and whether "Azathioprine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 0 | 2 | 2 |
| 2000 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 1 | 2 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Azathioprine" by people in Profiles.
-
Ioannou P, Tsagkaraki E, Vamvoukaki R, Kouvidou C, Krasagakis K, Chamilos G, Gikas A. Infective endocarditis due to Enterococcus faecalis manifesting as pemphigus foliaceus. Hellenic J Cardiol. 2019 May - Jun; 60(3):202-204.
-
Cheraghi N, Yasuda M, Deng A, Mailhot J. Azathioprine hypersensitivity presenting as neutrophilic dermatosis and erythema nodosum. Cutis. 2016 Jul; 98(1):E7-9.
-
Sarda G, Harvey R. Severe transaminitis in a paediatric patient with systemic lupus erythaematosus and a discussion of the literature. BMJ Case Rep. 2016 Apr 18; 2016:10.1136/bcr-2015-214159.
-
Karam S, Wali RK. Current State of Immunosuppression: Past, Present, and Future. Crit Rev Eukaryot Gene Expr. 2015; 25(2):113-34.
-
Samnaliev M, Lightdale JR. On the cost-effectiveness of the use of probiotics in inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2011 Nov; 53(5):473.
-
Brucato A, Brambilla G, Adler Y, Spodick DH, Canesi B. Therapy for recurrent acute pericarditis: a rheumatological solution? Clin Exp Rheumatol. 2006 Jan-Feb; 24(1):45-50.
-
Batra AK, Levey JM, Trister J, Patwardhan R. Pyoderma gangrenosum in a patient with collagenous colitis. J Am Acad Dermatol. 2003 Nov; 49(5 Suppl):S277-9.
-
Madden RL, Mulhern JG, Benedetto BJ, O'Shea MH, Germain MJ, Braden GL, O'Shaughnessy J, Lipkowitz GS. Completely reversed acute rejection is not a significant risk factor for the development of chronic rejection in renal allograft recipients. Transpl Int. 2000; 13(5):344-50.
-
Swanson C, Rubin M, Colquhoun S, Basadonna G, Asshinnik A, Perez R. FK 506-based immunosuppression in clinical pancreas transplantation. Transplant Proc. 1995 Dec; 27(6):3031.
-
Khauli RB, Wilson JM, Baker SP, Valliere SA, Lovewell TD, Stoff JS. Triple therapy in cadaveric renal transplantation: role of induction cyclosporine and targeted levels to avoid rejection. J Urol. 1995 Jun; 153(6):1805-9; discussion 1810.